On the heels of As of Monday January 5, 2026, patients will have access to the starter dose of the oral GLP-1, 1.5 mg, with additional strengths reported to be released by the end of the week
Kazimierska M, Lesniewska A, Bakker A, Diepstra A, Kasprzyk ME, Podralska M, et al
Xie, Y., Choi, T
Nausea causes retching that weakens the lower esophageal sphincter
Why Prior Semaglutide Dose Does Not Determine Your Starting Tirzepatide Dose This is a common patient question
Patients should also be aware that Saxenda typically increases resting heart rate by 2-3 beats per minute, which may require monitoring in those with pre-existing cardiovascular disease